Conmed Corporation
Clinical trials sponsored by Conmed Corporation, explained in plain language.
A medical technology company providing surgical instruments and devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scaffold aims to stop rotator cuff repairs from failing Results expected Dec 2026 (estimated)
-
New scaffold aims to stop rotator cuff repairs from failing
Disease control Recruiting nowThis study tests whether adding a BioBrace® implant during rotator cuff surgery helps the tendon heal better and reduces the chance of re-tearing. About 268 adults aged 40–70 with full-thickness tears will be randomly assigned to get surgery with or without the implant. The main …
Sponsor: CONMED Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Knee surgery gets a boost: BioBrace scaffold tested in 500 patients
Disease control Recruiting nowThis study is testing a device called BioBrace, a special scaffold that wraps around a tissue graft during ACL knee surgery to make it stronger. Researchers will follow 500 people aged 14 to 70 for up to 3 years to see if it improves knee function and is safe. The goal is to help…
Sponsor: CONMED Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC